Pluripotent embryonic stem cell is the critical ingredient for making complicated genetically engineered animals, which can be used for the production of many valuable biologics. ATGC was awarded this grant to utilize the most up-to-date knowledge on the ground state of pluripotency, to derive germline competent embryonic stem cells from the rabbit blastocyst. Success of the project will enable us to produce sophisticated genetically engineered rabbits that can be used for the production of therapeutic biologics such like human antibodies. For details of the technology please search Project Number 1R41OD023245 in NIH RePORTER.
No comment